Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels

Low levels of insulin-like growth factor binding protein-1 (IGFBP-1) have recently been associated with several risk factors for cardiovascular disease. The effects of estrogen replacement therapy (ERT) on plasma IGFBP-1 levels are, however, unclear. A double-blind, placebo-controlled study for 6 mo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 2000-03, Vol.149 (1), p.157-162
Hauptverfasser:	Paassilta, Marita, Karjalainen, Anna, Kervinen, Kari, Savolainen, Markku J, Heikkinen, Jorma, Bäckström, Ann-Christine, Kesäniemi, Y.Antero
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Cutaneous Administration, Oral Aged Biological and medical sciences Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Double-Blind Method Estradiol - administration & dosage Estrogen replacement therapy Estrogen Replacement Therapy - methods Female Follow-up study Hormones. Endocrine system Humans Hysterectomy Insulin-Like Growth Factor Binding Protein 1 - analysis Insulin-Like Growth Factor Binding Protein 1 - drug effects Insulin-like growth factor binding protein-1 Insulin-like growth factor I Insulin-Like Growth Factor I - analysis Insulin-Like Growth Factor I - drug effects Lipoprotein(a) Lipoprotein(a) - analysis Lipoprotein(a) - drug effects Medical sciences Middle Aged Pharmacology. Drug treatments Postmenopause Probability Sensitivity and Specificity Software
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!